key: cord-0920106-n26bbri9
authors: Rudnicka, Lidia; Rakowska, Adriana; Waskiel-Burnat, Anna; Kurzeja, Marta; Olszewska, Malgorzata
title: Mild to moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients.
date: 2021-05-26
journal: J Am Acad Dermatol
DOI: 10.1016/j.jaad.2021.05.020
sha: 5410237efb3d4bd39ce911af283d303c599857f3
doc_id: 920106
cord_uid: n26bbri9

nan

The study included 32 consecutive patients with alopecia areata. All patients had a 43 confirmed, mild to moderate COVID-19. Patient characteristics are presented in Table 1 44 and Supplemental Table1. In all patients the SALT (Severity of Alopecia Tool) was were: lichen planopilaris with oral lichen planus, pemphigus, and psoriasis. In 10/32 53 (31.3%) patients treatment was discontinued for 7-28 days because of COVID-19.

The SALT score values were as follows: 40,8 ± 28.6 (mean ± SD) before COVID-19 and 

Cyclosporine therapy during the COVID-19 80 pandemic

The immunology of COVID-19: is immune modulation 82 an option for treatment?

Rapidly 84 progressive alopecia areata totalis in a Covid-19 patient, unresponsive to tofacitinib

Short-term stress-related increasing cases of 87 alopecia areata during the COVID-19 pandemic

Italian Survey for the Evaluation of the Effects 89 of Coronavirus Disease 2019 (COVID-19) Pandemic on Alopecia Areata Recurrence

Table 1. Characteristics of 32 patients with alopecia areata and COVID-19